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The immune system must be educated to discriminate
between the body’s own tissues (‘self’) and foreign
pathogenic microorganisms (non-self). This ability is
acquired by T lymphocytes in the thymus (central toler-
ance) and it is further reﬁned by peripheral tolerance.
Errors in discrimination potentially result in autoimmune
diseases, such as type 1 diabetes, in which the insulin-
producing beta cells of the pancreas are destroyed by
T lymphocytes. In this issue of The EMBO Journal,F a n
et al (2009) describe how a failure of central tolerance to
insulin causes diabetes in a mouse strain resistant to
spontaneous autoimmune diabetes. Conversely, enhanced
central tolerance to insulin can prevent diabetes in dia-
betes-prone mice (French et al, 1997). Inducing or
preventing diabetes by controlling the immune response
to insulin is consistent with autoimmunity being the cause
of diabetes rather than a secondary response to tissue
damage.
Developing T cells are exposed to short peptides
derived from self proteins ‘presented’ in the antigen-binding
cleft of major histocompatibility complex (MHC) proteins,
highly polymorphic membrane-bound glycoproteins ex-
pressed on thymic epithelial cells. These cells transcribe
and translate numerous genes into proteins otherwise ex-
pressed in extrathymic organs (Derbinski et al, 2001). This
promiscuous expression is not for the function usually
associated with the protein, for example, glucose regulation
in the case of insulin, but for central tolerance—deletion from
the immune repertoire of immature T cells that recognize
antigen with high afﬁnity. Mutations in the transcription
factor Aire reduce thymic expression of peripheral antigens,
and result in widespread autoimmunity and in autoimmune
polyglandular syndrome type 1 (Mathis and Benoist,
2009). Furthermore, there is evidence that polymorphisms
in the insulin promoter affect its thymic expression
and increase the risk for diabetes (Pugliese et al, 1997;
Vaﬁadis et al, 1997).
Allelic variation in the MHC has long been associated with
autoimmune diseases. The association of type 1 diabetes with
MHC in humans and mice is the greatest for any genetic locus
with a complex disease. Although believed to be due to the
ability of these MHC alleles to mediate central tolerance to
pancreatic beta cell antigens, direct mechanistic evidence has
proven elusive. Fan et al have used mouse genetic technology
to eliminate the insulin gene from thymic epithelial cells
using cre recombinase driven by the Aire promoter, but
insulin was still expressed in the pancreas. Therefore,
T cells were not exposed to insulin peptides during their
development leaving insulin-speciﬁc T cells untouched by
negative selection. These H-2b-bearing C57BL6 mice, that are
not diabetes prone, developed diabetes by 3 weeks of age due
to apparent immune-mediated beta cell destruction asso-
ciated with demonstrable insulin-speciﬁc T and B cells. The
data provide direct conﬁrmation that lack of central tolerance
to one individual autoantigen, insulin, can cause diabetes.
They also conﬁrm that peripheral antigen expression in
thymic epithelial cells is essential because expression of
insulin itself, rather than other proteins with related cross-
reactive peptides, was required for sufﬁcient negative selec-
tion to avoid autoimmunity.
There are potential confounding factors in the experimen-
tal design. As mice have two insulin genes these experiments
were done in mice with global deletion of the insulin 1 gene
and conditional deletion of insulin 2 gene to ensure no
insulin expression in the thymic epithelium. Autoimmune
reactivity against the beta cells could be transferred to
unmodiﬁed recipient mice but diabetes did not occur. It is
possible that deletion of insulin may have occurred in other
cell types or that deletion of insulin may have reduced
selection of insulin-speciﬁc regulatory T cells. These caveats
need to be explored.
This experimental model represents an extreme genetic
case resulting in zero exposure of the developing immune
system to insulin. In non-transgenic mice (and probably also
in people), it is likely that some insulin-speciﬁc Tcells escape
central tolerance, but to a much less dramatic extent and thus
subsequent events are required, including the immune re-
sponse to spread to other beta-cell antigens, for diabetes to
occur. The data provide evidence that variation in insulin
presentation in the thymus—whether due to insulin expres-
sion, or structural variation in MHC–autoantigen peptide
afﬁnity—can cause autoimmune diabetes. At diagnosis,
patients with type 1 diabetes typically have autoantibodies
against a variable set of beta cell autoantigens, including (in
order of prevalence) glutamic acid decarboxylase, zinc trans-
porter ZnT8, tyrosine phosphatase IA-2 and insulin.
Increasingly, insulin autoimmunity is seen as the primary
driver rather than just one widely studied example of auto-
immunity against beta cell antigens. The effect of deleting
other beta cell antigens from the thymus in this way would be
of interest. Whether acquired variation in thymic insulin
presentation could explain some of the environmental impact
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thymic insulin expression in humans remain important
questions.
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